Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Clopidogrel is a potent inhibitor of platelet aggregation and has been used as an alternative, or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 male diabetic patient who underwent simultaneous kidney-pancreas transplantation was given clopidogrel as he was allergic to aspirin. He developed polyarthralgia one week later, followed in a few days by symmetrical migratory polyarthritis, which resolved completely on withdrawing the drug. The implications to clinical management in a transplant setting are discussed.

Original publication

DOI

10.1177/039463200601900221

Type

Journal article

Journal

Int J Immunopathol Pharmacol

Publication Date

04/2006

Volume

19

Pages

443 - 444

Keywords

Adult, Arthritis, Diabetes Mellitus, Type 1, Humans, Kidney Function Tests, Kidney Transplantation, Male, Pancreas Transplantation, Platelet Aggregation Inhibitors, Postoperative Complications, Ticlopidine, Uremia